An amendment, printed as amendment No. 63 in the Congressional Record of July 31, 1995, to prohibit the National Institute of Health from using funds appropriated in the bill to enter into contractual agreement with drug companies, unless such contracts include a reasonable pricing clause, whereby the drug company agrees to market all drugs developed with tax-payer funded research and development at a reasonable price. The amendment would allow NIH to waive the requirement if it is determined that a reasonable pricing structure would not be in the public interest.

failedUnited States· United States Congress· EN

Introduced

—

Last action

—

Status

On agreeing to the Sanders amendment (A024) Failed by recorded vote: 141 - 284 (Roll no. 624).

Records

Official amendment HAMDT 735 (104th) from United States at United States Congress. Status: On agreeing to the Sanders amendment (A024) Failed by recorded vote: 141 - 284 (Roll no. 624)..

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

amends → Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 1996

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/amendment/104th-congress/hamdt-735
Open data entity: https://api.congress.gov/v3/amendment/104/hamdt/735
us · 104-hamdt-735 · source updated 15 August 2021